Dispatch Biotherapeutics, Inc.
A DOL Labor Condition Application record spanning FY2024–2025. Review the filing volume, DOL certification record, and offered-wage context below.
- DOL LCA filings
- 3
- DOL-certified
- 100%
- Median offered wage
- $123,483
Philadelphia, PA NAICS: 541714
The DOL filing record for Dispatch Biotherapeutics, Inc.
U.S. Department of Labor's OFLC discloses 3 Labor Condition Application filings naming Dispatch Biotherapeutics, Inc. from FY2024 through FY2025, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs
How many H-1B petitions has USCIS approved for Dispatch Biotherapeutics, Inc.?
Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 2 H-1B petitions naming Dispatch Biotherapeutics, Inc. through FY2024, and approved nearly every one of them: 100% approved (2 approvals, 0 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.
The verdict
Dispatch Biotherapeutics, Inc. is listed in 3 DOL LCA filings, more filings than 67% of employer filers in this extract. DOL certified 100% of those LCAs; the median listed offered wage is $123,483. This is not a USCIS approval, hiring, or sponsorship ranking.
- 3
- DOL LCA filings, FY2024–FY2025
- 100%
- DOL-certified
- $123,483
- median offered wage
- Top 33%
- of employer filers by volume
According to U.S. Department of Labor OFLC LCA disclosure files (FY2024–FY2025). Based in Philadelphia, PA.
Dispatch Biotherapeutics, Inc. vs all U.S. employer filers by LCA volume
Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)
3 52221st of 122824 higher than 70,603 of 122,824 employer filers
Employer filers, banded by disclosed H-1B LCA filing count
Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source U.S. Department of Labor OFLC · FY2024–FY2025
LCA filing shape · Dispatch Biotherapeutics, Inc.
Derived from this employer's disclosed LCAs on file (FY2024–FY2025), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.
Offered-wage span on file: $100,000–$152,000 .
Title concentration
- Scientist III, Preclinical Candidate Development 1 · 33.3% · $152,000
- Scientist II 1 · 33.3% · $118,450
- Scientist I – Platform Discovery 1 · 33.3% · $100,000
Worksite counties
- PHILADELPHIA, PA 2 · 66.7%
- SAN FRANCISCO, CA 1 · 33.3%
Thin filer, multi-state worksites
Only 3 LCAs, but worksites already span 2 states (PA, CA). HQ Philadelphia, PA · DOL cert 100%.
Geographic Distribution
Where Dispatch Biotherapeutics, Inc. places H-1B workers across the United States
Recent LCA Filings
Latest H-1B labor condition applications filed by Dispatch Biotherapeutics, Inc.
| Job Title | Location | Salary | Status | Year |
|---|---|---|---|---|
| Scientist II | PHILADELPHIA, PA | $118,450 | Certified | FY2025 |
| Scientist III, Preclinical Candidate Development | San Francisco, CA | $152,000 | Certified | FY2024 |
| Scientist I – Platform Discovery | Philadelphia, PA | $100,000 | Certified | FY2024 |
Nationwide peers near Dispatch Biotherapeutics, Inc.'s 3-LCA band
Cross-state DOL neighbors for Dispatch Biotherapeutics, Inc. - LCA filing-count and offered-wage axes, outside PA.
Similar avg offered wage
Cross-state employer filers with a comparable average listed offered wage ($123,483 here).
Disclaimer: Informational only, not professional advice.
Read with Dispatch Biotherapeutics, Inc.
ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps TRACE-BOOK · CERT-LOCK · WAGE-PAR.
ABS(total_petitions) peer at 3 LCAs (Δ 0 heavier vs Dispatch Biotherapeutics, Inc.); CERT-SOFT · WAGE-BELOW vs this page's TRACE-BOOK · CERT-LOCK · WAGE-PAR.
ABS(total_petitions) peer at 3 LCAs (Δ 0 heavier vs Dispatch Biotherapeutics, Inc.); CERT-LOCK · WAGE-BELOW vs this page's TRACE-BOOK · CERT-LOCK · WAGE-PAR.
ABS(total_petitions) peer at 3 LCAs (Δ 0 heavier vs Dispatch Biotherapeutics, Inc.); CERT-LOCK · WAGE-PAR vs this page's TRACE-BOOK · CERT-LOCK · WAGE-PAR.
ABS(total_petitions) peer at 3 LCAs (Δ 0 heavier vs Dispatch Biotherapeutics, Inc.); CERT-LOCK · WAGE-BELOW vs this page's TRACE-BOOK · CERT-LOCK · WAGE-PAR.
PA pole at 13,463 LCAs stamps MEGA-BOOK · CERT-LOCK, farthest ABS(total_petitions) contrast from Dispatch Biotherapeutics, Inc.'s TRACE-BOOK.
Open the PA state board after the ABS peers. Dispatch Biotherapeutics, Inc. stamps TRACE-BOOK · CERT-LOCK inside that worksite mix.
Dispatch Biotherapeutics, Inc.'s WAGE-PAR · TRACE-BOOK stamps sit mid-band. Wage levels I-IV explain the floor behind the offer.
What to do with this profile
Use the DOL LCA record for Dispatch Biotherapeutics, Inc. to compare filing volume and offered wages, not USCIS outcomes.
- Dispatch Biotherapeutics, Inc. filed 3 LCAs in the indexed extract (100% certified in-file). That volume ranks higher than 67% of employer filers.
- Compare offered wages and certification rates against 6 same-state filers on the chart above. Jump to compare
- See how other employers in PA rank on LCA filing volume this vintage. PA filers
- Read what an LCA filing records versus a USCIS petition approval. LCA vs petition
DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.
Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.